Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most frequent primitive cancer of the liver, accounting for 90% of all recorded cases. HCC is the third most common cause of cancer-related death, with a 5-year survival rate of just 3%. In terms of the advanced stages, systemic treatments have a...

Descripción completa

Detalles Bibliográficos
Autores principales: Laface, Carmelo, Fedele, Palma, Maselli, Felicia Maria, Ambrogio, Francesca, Foti, Caterina, Molinari, Pasquale, Ammendola, Michele, Lioce, Marco, Ranieri, Girolamo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406380/
https://www.ncbi.nlm.nih.gov/pubmed/36011021
http://dx.doi.org/10.3390/cancers14164028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406380/
https://www.ncbi.nlm.nih.gov/pubmed/36011021
http://dx.doi.org/10.3390/cancers14164028

Ejemplares similares